Anti-Mullerian Hormone: A Potential Marker for Recruited Non-Growing Follicles of Ovarian Pool in Women with Polycystic Ovarian Syndrome

    Saikumar P, Vs Kalai Selvi, Prabhu K, P. C. Venkatesh, Prashanth Krishna
    Image of study
    TLDR AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.
    In the 2013 study involving 120 infertile women, researchers found that Anti-Mullerian Hormone (AMH) levels were significantly higher in the 60 women with Polycystic Ovarian Syndrome (PCOS) than in the 60 controls with regular cycles. The study determined that AMH could be used as a marker for recruited non-growing follicles in the ovaries of women with PCOS. With a cut-off point of 3.34 ng/ml for AMH, the diagnostic accuracy was high, with a sensitivity of 98%, specificity of 93%, Positive Predictive Value (PPV) of 93%, and Negative Predictive Value (NPV) of 98%. These findings suggest that AMH is a reliable diagnostic tool for PCOS and reflects the number of small follicles, indicating the severity of follicular arrest in PCOS patients.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community I wish we didn’t have to live with this….

       61 upvotes 6 years ago
      The struggles of hair loss at a young age and available treatments, such as medication (Finasteride, Minoxidil, Dutasteride, Derma Rolling) and potential options for hair systems or cloning in Japan. People discussed their own experiences with trying to cope with the emotional aspects of this condition.

      community 9 months on Finasteride 1,25mg + HRT

      in Transgender  14 upvotes 1 year ago
      The conversation is about the results of using hormone replacement therapy (HRT) with estrogen and finasteride for hair loss, and switching from finasteride to bicalutamide as an anti-androgen treatment. The user shared before and after photos to discuss the effectiveness of these treatments.

    Related Research

    2 / 2 results